APA

Kawahira M., Yokota T., Hamauchi S., Kawai S., Yoshida Y., Onozawa Y., Tsushima T., Todaka A., Machida N., Yamazaki K., Fukutomi A. & Yasui H. (20190109). Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. : International journal of clinical oncology.

Chicago

Kawahira Masahiro, Yokota Tomoya, Hamauchi Satoshi, Kawai Sadayuki, Yoshida Yukio, Onozawa Yusuke, Tsushima Takahiro, Todaka Akiko, Machida Nozomu, Yamazaki Kentaro, Fukutomi Akira and Yasui Hirofumi. 20190109. Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. : International journal of clinical oncology.

Harvard

Kawahira M., Yokota T., Hamauchi S., Kawai S., Yoshida Y., Onozawa Y., Tsushima T., Todaka A., Machida N., Yamazaki K., Fukutomi A. and Yasui H. (20190109). Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. : International journal of clinical oncology.

MLA

Kawahira Masahiro, Yokota Tomoya, Hamauchi Satoshi, Kawai Sadayuki, Yoshida Yukio, Onozawa Yusuke, Tsushima Takahiro, Todaka Akiko, Machida Nozomu, Yamazaki Kentaro, Fukutomi Akira and Yasui Hirofumi. Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. : International journal of clinical oncology. 20190109.